Synthesis and characterization of imidazopyrazine derivatives as VAV1 inhibitors

被引：0
|
作者：
Gerspacher, Marc [1 ]
Skaanderup, Philip [1 ]
Imbach-Weese, Patricia [1 ]
Metoul, Lionel Doumampouom [1 ]
Roehn-Carnemolla, Esther [1 ]
Arz, Dorothee [1 ]
Garlot, Audrey-Laure [1 ]
Remond, Anne-Catherine [1 ]
Eric, Vangrevelinghe [1 ]
Knapp, Mark [2 ]
Lingel, Andreas [1 ]
Stucke, Volker [1 ]
Chene, Patrick [1 ]
Hofmann, Francesco [1 ]
机构：
[1] Novartis Pharma AG, Novartis Inst BioMed Res Basel, Basel, Switzerland
[2] Novartis Inst BioMed Res, Emeryville, CA USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2018年 / 256卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
101
引用
收藏
页数：1
相关论文
共 50 条
  • [31] VAV1 Gene Polymorphism is Associated With Kidney Allograft Rejection
    Wisniewska, Magda
    Banach, Boleslaw
    Malinowski, Damian
    Domanski, Leszek
    Sroczynski, Tomasz
    Dziedziejko, Violetta
    Safranow, Krzysztof
    Pawlik, Andrzej
    TRANSPLANTATION PROCEEDINGS, 2021, 53 (05) : 1528 - 1531
  • [32] Phosphatidylinositol Monophosphates Regulate Optimal Vav1 Signaling Output
    Rodriguez-Fdez, Sonia
    Citterio, Carmen
    Francisco Lorenzo-Martin, L.
    Baltanas-Copado, Jesus
    Llorente-Gonzalez, Clara
    Corbalan-Garcia, Senena
    Vicente-Manzanares, Miguel
    Bustelo, Xose R.
    CELLS, 2019, 8 (12)
  • [33] Structural and energetic mechanisms of cooperative autoinhibition and activation of vav1
    Tomchick, Diana R.
    Yu, Bingke
    Martins, Ilidio R. S.
    Li, Pilong
    Amarasinghe, Gaya K.
    Umetani, Junko
    Fernandez-Zapico, Martin E.
    Billadeau, Daniel D.
    Machius, Mischa
    Rosen, Michael K.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2011, 67 : C121 - C121
  • [34] Recurrent VAV1 Abnormalities in Angioimmunoblastic T Cell Lymphoma
    Komori, Daisuke
    Sakata-Yanagimoto, Mamiko
    Nuhat, Sharna Tanzima
    Fukumoto, Kota
    Fujisawa, Manabu
    Nishizawa, Shoko
    Matsue, Kosei
    Izutsu, Koji
    Nakamura, Naoya
    Yoshida, Kenichi
    Ogawa, Seishi
    Chiba, Shigeru
    BLOOD, 2016, 128 (22)
  • [35] Vav1 Promotes B-Cell Lymphoma Development
    Shalom, Batel
    Farago, Marganit
    Salaymeh, Yaser
    Sebban, Shulamit
    Pikarsky, Eli
    Katzav, Shulamit
    CELLS, 2022, 11 (06)
  • [36] VAV1 controls inflammation in experimental autoimmune encephalomyelitis (EAE)
    Guerreiro-Cacais, Andre Ortlieb
    Beyeen, Amennai Daniel
    N'Diaye, Marie
    Jagodic, Maja
    Olsson, Tomas
    JOURNAL OF NEUROIMMUNOLOGY, 2012, 253 (1-2) : 69 - 69
  • [37] Structural and Energetic Mechanisms of Cooperative Autoinhibition and Activation of Vav1
    Yu, Bingke
    Martins, Ilidio R. S.
    Li, Pilong
    Amarasinghe, Gaya K.
    Umetani, Junko
    Fernandez-Zapico, Martin E.
    Billadeau, Daniel D.
    Machius, Mischa
    Tomchick, Diana R.
    Rosen, Michael K.
    CELL, 2010, 140 (02) : 246 - 256
  • [38] The association of Sam68 with Vav1 contributes to tumorigenesis
    Lazer, Galit
    Pe'er, Liron
    Schapira, Vered
    Richard, Stephane
    Katzav, Shulamit
    CELLULAR SIGNALLING, 2007, 19 (12) : 2479 - 2486
  • [39] Essential role for Vav1 in activation, but not development, of γδ T cells
    Swat, W
    Xavier, R
    Mizoguchi, A
    Mizoguchi, E
    Fredericks, J
    Fujikawa, K
    Bhan, AK
    Alt, FW
    INTERNATIONAL IMMUNOLOGY, 2003, 15 (02) : 215 - 221
  • [40] Recognition and activation of rho GTPases by Vav1 and Vav2 guanine nucleotide exchange factors
    Heo, J
    Thapar, R
    Campbell, SL
    BIOCHEMISTRY, 2005, 44 (17) : 6573 - 6585
12345